<DOC>
	<DOCNO>NCT00196417</DOCNO>
	<brief_summary>Randomised , double blind trial non-intensive care trauma patient compare unfractionated heparin ( UFH ) low-molecular-weight heparin ( LMWH ) heparin-induced thrombocytopenia ( HIT ) .</brief_summary>
	<brief_title>The HIT-TRAP Trial</brief_title>
	<detailed_description>This randomise , double blind trial include trauma patient need thrombosis prophylaxis heparin . Patients receive either unfractionated heparin ( UFH ) low-molecular-weight heparin ( LMWH ) . Heparin-induced thrombocytopenia ( HIT ) antibody measure day 1 10 . There daily platelet count . On discharge ultrasound doppler low extremity perform rule deep vein thrombosis ( DVT ) . Three month discharge every patient answer questionnaire thromboembolic complication follow discharge . The key question study whether two heparin cause HIT-antibodies differ frequency , yes , whether difference lead different clinical outcome .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Certoparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>traumasurgical patient consent give minimum age 18 expect inpatient period least 7 day need thrombosis prophylaxis heparin intolerance one study drug malignancy life expectancy &lt; 3 month pregnancy/lactation drug alcohol abuse fibrinolytic therapy need extracorporal circulation ( e.g . cardiopulm . bypass , hemodialysis ) study entry participation another clinical trial within 30 day prior intend inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>heparin-induced thrombocytopenia</keyword>
	<keyword>HIT</keyword>
	<keyword>unfractionated heparin</keyword>
	<keyword>UFH</keyword>
	<keyword>low-molecular-weight heparin</keyword>
	<keyword>LMWH</keyword>
	<keyword>thrombosis prophylaxis</keyword>
	<keyword>HIT-antibody</keyword>
</DOC>